SANA · Sana Biotechnology, Inc.

Summary

Sana Biotechnology reclassified director Steven D. Harr from Class I to Class III to rebalance board classes, effective April 22, 2026.

Key takeaways

• Steven D. Harr resigned as Class I director and was reappointed as Class III director to rebalance board classes.
• The reclassification was effective April 22, 2026, and his service is deemed uninterrupted.
• Board now has three directors in each class, complying with the Certificate of Incorporation.